B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients

BackgroundVaccination is considered as most efficient strategy in controlling SARS-CoV-2 pandemic spread. Nevertheless, patients with autoimmune inflammatory rheumatic diseases receiving rituximab (RTX) are at increased risk to fail humoral and cellular responses upon vaccination. The ability to pre...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ana-Luisa Stefanski, Hector Rincon-Arevalo, Eva Schrezenmeier, Kirsten Karberg, Franziska Szelinski, Jacob Ritter, Yidan Chen, Bernd Jahrsdörfer, Carolin Ludwig, Hubert Schrezenmeier, Andreia C. Lino, Thomas Dörner
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2022-04-01
Saila:Frontiers in Immunology
Gaiak:
RTX (rituximab)
B-cells
vaccination
SARS – CoV – 2
prediction
Sarrera elektronikoa:https://www.frontiersin.org/articles/10.3389/fimmu.2022.822885/full
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak